Registration does not represent any form of accreditation, certification or approval by the UK Competent Authority(MHRA).
Where a conformity assessment certificate is listed as expired, existing products already placed on the market prior to the expiry may not be affected by this expiry and can continue to be used. This expiry stops new products being placed on the market until there is a new certificate of conformity.

Back to MHRA

Manufacturer's By Device Acute promyelocytic leukaemia (APL) genetic mutation IVD kit nucleic acid technique (NAT)-Acute promyelocytic leukaemia (APL) genetic mutation IVD kit nucleic acid technique (NAT)

Displaying 1 to 4 of 4

Page(s) 1

Manufacturer	Address	Authorised Representative	Address	Date Registered	MHRA Reference Number
3B BlackBio Biotech India Limited	7-C Industrial Area Govindpura Bhopal Madhya Pradesh 462023 India	Wellkang Ltd	Enterprise Hub NW Business Complex 1 Beraghmore Road Derry Northern Ireland BT48 8SE Northern Ireland United Kingdom	12/06/2021	20343
DiaSorin Molecular LLC	11331 Valley View St. Cypress California 90630 United States	DiaSorin Italia S.p.A. UK Branch	Central Road Dartford DA1 5LR England United Kingdom	12/07/2021	20351
Diatech Pharmacogenetics S.r.l	Via Ignazio Silone 1b JESI Ancona 60035 Italy	BS Partnership Ltd	41 Dan-Y-Coed Road Cyncoed CARDIFF CARDIFF WALES CF23 6NB Wales United Kingdom	02/13/2023	27799
QIAGEN GmbH	QIAGEn GmbH Qiagen Str. 1 Hilden Mettmann Düsseldorf 40724 Germany	QIAGEN Manchester Ltd.	QIAGEN Manchester Ltd. Citylabs 2.0 200 Hathersage Road Manchester M13 0BH England United Kingdom	03/19/2021	12724

Manufacturer's By Device Acute promyelocytic leukaemia (APL) genetic mutation IVD kit nucleic acid technique (NAT)-Acute promyelocytic leukaemia (APL) genetic mutation IVD kit nucleic acid technique (NAT)

Contact details